Mucha-Habermann disease-like eruptions due to Tegafur.
The first case of Mucha-Habermann disease-like drug eruptions due to Tegafur is reported. A 59-year-old man noticed various skin lesions after he had taken 300 mg of Tegafur daily for about 200 days. The patient had papulonecrotic eruptions on his trunk and extremities. The histology from a papular lesion revealed epidermal necrosis surrounded by spongiosis, perivascular inflammatory infiltrations composed of lymphocytes and erythrocytes, and endothelial swelling. The etiology of Mucha-Habermann disease is not known, but an immune mechanism may be supported by our case.
Kawamura
K
K
Department of Dermatology, Nagoya City University Medical School, Japan.
Tsuji
T
T
Kuwabara
Y
Y
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D017514:Pityriasis Lichenoides / Q000139:chemically induced* / Q000473:pathology; D012867:Skin / Q000473:pathology; D005641:Tegafur / Q000009:adverse effects*
D000964:Antimetabolites, Antineoplastic; D005641:Tegafur